Phase 1 Clinical Trials
Clinilabs Drug Development Corporation provides full range of CNS Phase I capabilities, with extensive experience in early phase studies required for regulatory approval. We offer expertise that provides a sound foundation for all Phase I projects.
First in human
First in class
Single ascending dose (SAD)
Multiple ascending dose (MAD)
Bioequivalence (BE)
Drug – drug interaction studies
Drug – alcohol interactions studies
Food effect studies
Pharmacokinetic (PK) studies
Pharmacodynamic (PD) studies
Kinetic-dynamic relationships
If you think compliance is expensive, try non-compliance
– Former US Attorney General Paul McNulty